Skip to main content

Zusammenfassung

Die Erörterung der Gestose im Rahmen der Weiterbildungsreihe einer anästhesiologischen Fachzeitschrift scheint nur auf den ersten Blick verwunderlich. Die vielgestaltige Symptomatik der Erkrankung, die teilweise dramatische Progredienz der Krankheitssymptome und das Fehlen einer kausalen Therapie erfordern eine hohe Fachkompetenz aller an der Behandlung von Gestosepatientinnen beteiligten Ärzte. In diesem Beitrag werden die wichtigsten Erkenntnisse zum Erkrankungskomplex„Gestose“ zusammengefaßt, die für die anästhesiologische und intensivmedizinische Behandlung von Patientinnen mit Gestose bedeutsam sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.95
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. CLASP (collaborative Low-Dose Aspirin Study in Pregnancy) Collaborative Study Group (1994) CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 343:619–629

    Article  Google Scholar 

  2. Brown M,Zammit V,Mitar DM,Whitworth JA (1992)Extracellular fluid volumes in pregnancy-induced hypertension. J Hypertens 10:61–68

    Article  PubMed  CAS  Google Scholar 

  3. Brown MA (1995) The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol 22:781–791

    Article  PubMed  CAS  Google Scholar 

  4. Davey DA, MacGillivray I (1988) The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158:892–898

    PubMed  CAS  Google Scholar 

  5. Donaldson JO (1992)The case against magnesium sulfate for eclamptic convulsions. Int J Obstet Anesth 1:159–166

    Article  PubMed  CAS  Google Scholar 

  6. Eclampsia Trial Collaborative Group (1995)Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 345:1455–1463

    Google Scholar 

  7. Gallery EDM (1995)Hypertension in pregnancy: Practical management recommendations. Drugs 49:555–562

    Article  PubMed  CAS  Google Scholar 

  8. Knox TA,Olans LB (1996)Liver disease in pregnancy. New Engl J Med 335:569–575

    Article  PubMed  CAS  Google Scholar 

  9. Lucas MJ, Leveno KJ, Cunningham FG (1995)A comparison of magnesium sulfate with Phenytoin for the prevention of eclampsia. New Engl J Med 333:201–205

    Article  PubMed  CAS  Google Scholar 

  10. Mushambi MC, Halligan AW, Williamson K (1996)Recent developments in the pathophysiology and management of pre-eclampsia. Br J Anaesth 76:133–148

    PubMed  CAS  Google Scholar 

  11. Pipkin FB, Growther C, De Swiet M, Duley L, Judd A, Lilford RJ, Onwude J, Prentice C, Redman CWG, Roberts J,Thornton J, Walker J (1996)Where next for prophylaxis against pre-eclampsia. Br J Obstet Gynaecol 103:603–607

    Article  Google Scholar 

  12. Schiff P, Pelegg E, Goldenberg N, Rosenthal T, Ruppin R, Tamarkin M, Barkai G, Ben-Baruch G, Blankstein J, Goldman B, Mashiach S (1989) The use of Aspirin to prevent pregnancy induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 321:351–356

    Article  PubMed  CAS  Google Scholar 

  13. Sibai BM (1990)Eclampsia — VI.Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 163:1049–1055

    PubMed  CAS  Google Scholar 

  14. Sibai BM, Mercer BM, Schiff E, Friedman SA (1994)Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks’ gestation: A randomized controlled trial. Am J Obstet Gynecol 171:818–822

    PubMed  CAS  Google Scholar 

  15. Sibai BM, Ramadan MK, Usta I, Salama BM, Friedman SA (1993)Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169:1000–1006

    PubMed  CAS  Google Scholar 

  16. Sibai BM, Ramanathan J (1992) The case for magnesium sulfate in preeclampsia-eclampsia.Int J Obstet Anesth 1:167–175

    Article  PubMed  CAS  Google Scholar 

  17. Taner CE, Hakverdi AU, Aban M, Erden AC, Özelbaykal U (1996) Prevalence, management and outcome in eclampsia. Int J Gynecol Obstet 53:11–15

    CAS  Google Scholar 

  18. Visser W, Wallenburg HCS (1995) Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 102:111–117

    Article  PubMed  CAS  Google Scholar 

  19. Wallace DH, Levens KJ, Cunningham GF, Giesecke AH, Sheaver VE, Sidawi JE (1995)Randomized comparison of general and regional anesthesia for cesaren delivery in pregnancies complicated by servere preeclampsia. Obstert Gynaecol 86:193–199

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Frey, L. (1998). Gestose und HELLP-Syndrom. In: Bardenheuer, H.J., Forst, H., Larsen, R., Rossaint, R., Spahn, D.R. (eds) Der Anaesthesist Weiterbildung für Anästhesisten 1998. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72265-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72265-3_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-64711-9

  • Online ISBN: 978-3-642-72265-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics